Curt LaBelle

Curt LaBelle, Board Member at Novocuff, Inc.

Curt LaBelle is the Head of Healthcare Private Equity at AXA IM Alts and a newly appointed Board Member of Novocuff, Inc. after leading their $26 million Series A funding round.157

Some key facts about Curt LaBelle:

• He earned both an MD and MBA from Columbia University.46
• LaBelle has over 21 years of experience investing in and operating healthcare companies.46
• He has served as a board member or observer for many successful healthcare companies over the past 16+ years.8
• LaBelle is excited to join Novocuff's Board and work with the company and co-investors to develop a solution for reducing preterm births.5

Novocuff is a medical device company dedicated to improving pregnancy outcomes and reducing preterm births caused by PPROM and cervical shortening.12 The $26 million Series A funding round led by LaBelle will support Novocuff's pivotal clinical trial, marketing authorization, team expansion, and early commercialization of their Cervical Control System device.123